Dengue is a mosquito-borne virus that may be thriving because of a
lack of immunity among the population of the Indian Ocean island, or
because the virus is simply causing more symptoms than it did in
previous years, the WHO said.
This year there have been 1,816 dengue cases confirmed, as of April
23. All of them were "autochthonous" - local rather than imported by
tourists and travelers. In the week to April 23, there were 428
probable and confirmed cases reported, compared to fewer than 100 in
all of 2017.
"Although sporadic autochthonous dengue fever cases and clusters
have been reported in Réunion before, the upsurge of cases since the
beginning of 2018 is unprecedented," the WHO said.
"Réunion is a popular tourist destination and the likelihood of
dengue virus introduction to other countries is heightened by the
current outbreak."
There have been 50 hospitalizations on La Reunion this year compared
to 12 in all of 2017, the WHO said.
Officials at the French health ministry were not immediately
available for comment.
[to top of second column] |
Dengue is the world's fastest-growing infectious disease, afflicting
hundreds of millions of people worldwide. It causes half a million
life-threatening infections and kills about 20,000 people, mostly
children, annually.
The world's only licensed vaccine against dengue, Sanofi's Dengvaxia,
is at the center of a health scare in the Philippines where the
government suspended its use last year amid safety fears.
Last month the WHO said Dengvaxia should only be used after testing
on individuals to assess whether they have ever been exposed to the
infection.
In 2016, the Haut Conseil de la Sante Publique, a public body close
to France's health ministry advised against the use of Dengvaxia in
the country's overseas territories, Reuters reported in December.
(Reporting by Tom Miles; Additional reporting by Matthias Blamont;
Editing by Susan Fenton)
[© 2018 Thomson Reuters. All rights
reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |